During the last 30 years, deep brain stimulation (DBS) has evolved into the clinical standard
of care as a highly effective treatment for advanced Parkinson's disease. Careful patient …

Deep brain stimulation (DBS) of the subthalamic nucleus (STN) or globus pallidum internus
(GPi) improves motor functions in patients with Parkinson's disease (PD) but may cause a …

Importance Selection of the best deep brain stimulation (DBS) target—subthalamic nucleus
(STN) or globus pallidus interna (GPi)—for treatment of motor complications in Parkinson …

OBJECTIVE Deep brain stimulation (DBS) is effective in the management of patients with
advanced Parkinson's disease (PD). While both the globus pallidus pars interna (GPi) and …

La enfermedad de Parkinson es la segunda causa de enfermedad neurodegenerativa
crónica progresiva, tiene una alta prevalencia e incidencia, genera un alto impacto en la …

Clinical populations with basal ganglia pathologies may present with language production
impairments, which are often described in combination with comprehension measures or …

Introduction: Although the benefit in motor symptoms for well-selected patients with deep
brain stimulation (DBS) has been established, cognitive declines associated with DBS can …

METHODS Details of the systematic literature review are provided in the full text of this
guideline (https://www. cns. org/guidelines/deep-brain-stimulation-parkinsons-disease). A …

Background Deep brain stimulation (DBS) of either the subthalamic nucleus (STN) or the
globus pallidus interna (GPi) can reduce motor symptoms in patients with Parkinson's …

Objective To compare the efficacy of subthalamic nucleus (STN) and globus pallidus
internus (GPi) deep brain stimulation (DBS) on reducing levodopa‐induced dyskinesia (LID) …